AzTrials
AzTrials

Deglutition DisordersDARC-VADOCNCT04800783

Diagnostic Accuracy of Aerodigestive Ultrasound for Predicting Swallowing Disorders

A study testing Swallowing ultrasound in people with Deglutition Disorders, run by Hopital Forcilles at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Swallowing disorders management requires an accurate recognition of implicated anatomical structures and pathways. The usual clinical assessment of swallowing disorders lacks reliability and accuracy. The gold standard remains the videofluoroscopy. However, this imaging technique lacks reliability and standardisation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Deglutition Disorders
What is being tested?
Swallowing ultrasound
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
124 participants
Where
1 siteFrance
Study dates
5 Mar 2021to 4 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Outpatients refered to swallowing assessment at the Forcilles' hospital;
  • Medical indication to perform a videofluoroscopy;
  • Ultrasonographer available;
  • Age > 18 years old;
  • Membership of a social insurance sheme;
  • Patient provides consent.

Who cannot join

  • Previous laryngectomy surgery;
  • Refusal to participate in the study;
  • Known pregnancy;
  • Person subject to judicial health protection;
  • Cognitive disorder incompatible with the understanding of instructions;
  • Patient under guardianship or curatorship.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Forcilles

    Férolles-Attilly, Île-de-France Region, 77150

Other trials in France

About this study

Official title: Development and Assessment of a New Ultrasound Score to Diagnose Swallowing Disorders in at Risk-out-patients

Swallowing disorders management requires an accurate recognition of implicated anatomical structures and pathways. The usual clinical assessment of swallowing disorders lacks reliability and accuracy. The gold standard remains the videofluoroscopy. However, this imaging technique lacks reliability and standardisation. Moreover, videofluoroscopy is not easily available, time and material consuming and exposes patients to ionisation. Ultrasound imaging, which can be performed at the patient's bedside, is a non-invasive tool. It allows the evaluation of the main structures involved in all the swallowing pathways and may be a promising tool to assess the swallowing disorders. An ultrasound predictive model has never been developed to diagnose swallowing disorders.

The investigators aim to develop an ultrasound predictive model to diagnose swallowing disorders, and assess its reliability and accuracy.

Read more

One hundred outpatients at risk of swallowing disorders (neck cancer, neurological diseases, previous ICU stay) will be enrolled in the Dysphagia Diagnostic Unit at the Forcilles' Hospital, during a 2-year period.

All patients will undergo a clinical examination by a speech-language therapist, and a videofluoroscopy imaging in order to diagnose swallowing disorders. Then, an ultrasound examination will be performed by the ultrasonographer. The ultrasonographer will be blinded from the patient's status and previous clinical and imaging assessments. Severity of the swallowing disorder will be assessed by the Dysphagia Outcome and Severity Scale.

The tongue kinetics and thickness, the laryngeal movement and the suprahyoid muscles thickness and echogenicity will be assessed by ultrasonography.

Inter- and intra-reliability of ultrasound examination will be calculated. The threshold of each ultrasound measurement allowing the swallowing disorders will be estimated using the ROC curve analysis. Sensitivity and specificity of each ultrasound measurement will be estimated. A global ultrasound predictive model will be developed after selecting variables in logistic multivariable regression. Diagnostic accuracy of the global predictive model will also be assessed.

The investigators hope a high reliability and accuracy of the ultrasound predictive model in the swallowing disorders diagnostic. As ultrasonography is easy-to-perform, rapidly available, non-invasive and inexpensive, it may be a valuable alternative to videofluoroscopy in swallowing disorder diagnostic.

Read the detailed description

Swallowing disorders management requires an accurate recognition of implicated anatomical structures and pathways. The usual clinical assessment of swallowing disorders lack of reliability and accuracy. The gold standard remains the videofluoroscopy. However, this imaging technique lacks reliability and standardisation. Moreover, videofluoroscopy not easily available is time and material consuming and implies ionisation. Ultrasound imaging, which can be performed at the patient's bedside, is a non-invasive tool. It allows the evaluation of the main structures involved in all the swallowing pathways and may be a promising tool for swallowing disorders assessment.

The investigators aim to develop an ultrasound predictive model to diagnose swallowing disorders, and assess its reliability and accuracy.

The investigators hope a high reliability and accuracy of the ultrasound predictive model in the swallowing disorders diagnostic. As ultrasonography is easy-to-perform, rapidly available, non-invasive and inexpensive, it may be a valuable alternative to videofluoroscopy in swallowing disorders diagnostic.

  1. Hypothesis The investigators hypothesise that a new ultrasound predictive model is valid and reliable to diagnose swallowing disorder.
  2. Objectives Primary objective:
  • To create a new ultrasound predictive model based on the most relevant ultrasound measurements of the swallowing structures. Secondary objectives:
  • To assess the accuracy of the ultrasound predictive model in the swallowing disorders diagnostic;
  • To assess the inter- and intra-reliability of the ultrasound measurements;
  • To assess the accuracy of each ultrasound measurements.
  1. Study design: The prospective observational single-centre study will be performed per the ethical standards of the Declaration of Helsinki and will be reported according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.
  2. Population: One hundred outpatients at risk of swallowing disorders (neck cancer, neurological diseases, previous ICU stay) will be enrolled in the Dysphagia Diagnostic Unit at the Forcilles' Hospital, during a 2-year period. All consecutive patients will be screened at hospital admission, and will be included if they satisfy the eligibility criteria. All patients will provide oral consent to participate, in accordance with the clinical research French laws. Duration of the patient's participation will take 3 hours.
  3. Data collection Data will be recorded using a local case report form. Demographic data, comorbidities, medical and surgical history, reason for swallowing assessment will be recorded at inclusion. Clinical, videofluoroscopy and ultrasound measurements will also be recorded. On-site monitoring is planned every month. Participants will first undergo an ultrasound examination, then the clinical examination and videofluoroscopy imaging.
  4. Ultrasound examination: Ultrasonography will be performed using a Sonosite E2 Expert ultrasound device (Digital Color Doppler Ultrasound System; Sonoscape medical corp. China) with a 7-10 MHz linear and a 3-5 MHz probes. Detailed information for ultrasound procedure is described in the research protocol. Ultrasonography will be performed with the patients in near-to-supine position (30°). The hyoid bone movement, tongue kinetics and geniohyoid muscle measurement will be performed in a sagittal plane with the curvilinear probe. The probe will be placed between the posterior border of the symphysis and the anterior margin of the hyoid bone. The anterior belly of digastric and geniohyoid muscles evaluation will be performed in a frontal plane with the linear probe. The probe will be placed in the submandibular area, behind the symphysis. Ultrasonographer will be blinded from all patients' status and previous examination. Reliability will be assessed in the first twenty participants. All ultrasound measurements will be repeated twice by the first ultrasonographer to assess the intra-operator reliability. A second ultrasound operator will perform all the ultrasound measurement, allowing the inter-operator reliability evaluation.
  5. Videofluoroscopy (VFSS): VFSS is a radiographic procedure that provides a direct, dynamic view of oral, pharyngeal, and upper oesophageal function during swallowing. The radiologist and SLP work as a team to follow a standard protocol for conducting this examination. During this procedure, the speech-language therapist presents food and fluid mixed with barium. The barium is necessary to view structures via videofluoroscopy during the swallow. The following procedure will be followed: 5 ml of thin fluid; 5 ml of ultra-thick liquid; 5 ml of solid aliment, then 30 ml of thin fluid. The VFSS allow the assessment of the characteristics of the swallow and the patterns of bolus movement, including initiation of the swallow, nasopharyngeal reflux, pharyngeal clearance, and laryngeal penetration and aspiration. At any time, the radiologist may not initiate or stop the examination if it may be harmful to the patient. The reason to stop the test will be recorded. In case of penetration or aspiration, the speech language therapist will use the 'Penetration-Aspiration Scale'.
  6. Statistical plan: Continuous variables will be expressed as the mean (± standard deviation) and compared using the Student's t test if the null hypothesis is not rejected by the Shapiro-Wilk test. Continuous variables will be expressed as the median (interquartile range) and compared with the Mann-Whitney U or Kruskal-Wallis test if the null hypothesis is rejected by the Shapiro-Wilk test. For categorical variables, the proportions of patients in each category will be calculated. Then the groups will be compared using Chi squared test. Continuous ultrasound variables will be dichotomised or grouped by class, depending on the linear relation between the logit of the swallowing disorder diagnostic and the ultrasound variable. The threshold for continuous ultrasound variables will be calculated with the ROC curve analysis. A multivariate logistic regression model will be carried out to assess the relation between swallowing disorders and ultrasound measures associated in univariate analyses. All statistically significant ultrasound variables will be included in the model. Variable selection will be stepwise, based on Akaike Information Criterion. To check multicollinearity between independent variables, the variance inflation factor will be calculated before performing multivariate logistic regression. Multicollinearity will be regarded as present when the variance inflation factor is > 5. Goodness of fit will be assessed by Hosmer-Lemeshow method. The outcome of each ultrasound variable from the multivariable logistic regression will be used to weight it in the global ultrasound predictive model. Intra- and inter-operator reliability will be assessed using the kappa coefficient for categorical variables or intra-class coefficients for continuous variables. For all tests, a p-value ≤ 0.05 will be considered statistically significant. All statistical analysis will be made using R software (version 3.6.1, www.R-project.org).
  7. Sample size calculation:

The investigators based the sample size calculation on the number of independent variables which will be included in the logistic multivariable regression model. The investigators use the criterion of one variable per 10 events for binary logistic regression analysis. The investigators plan to include the 5 most relevant ultrasound measures in the model. As prevalence of swallowing disorders in our unit is estimated at 0.5, the investigators plan a sample size of 100 patients.

Reliability will be assessed on the first 20 patients. With an 80% predicted kappa, a minimal value of the kappa of 50%, 2 observations, a 95% certainty and a 80% power, 20 patients will be required.

Being tested
Swallowing ultrasound
Keywords
Swallowing disorders, Ultrasonography, Outpatients, Laryngeal, Tongue, Validation study
Medical subject headings
Deglutition Disorders, Laryngeal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Swallowing ultrasoundDiagnostic test

    Ultrasound assessment of the tongue movement and thickening, the geniohyoid and suprahyoid muscles echogenicity, thickness and thickening, the hyoid bone elevation, and the number of swallowing trial.

Study groups in NCT04800783
Study groupRoleWhat they receive
Swallowing disorders cohortOtherAll included patients will undergo an ultrasound assessment of the oral and laryngeal structures involved in the swallowing process.
Receives: Diagnostic Test: Swallowing ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Swallowing ultrasound predictive model development

    Selection of the most contributive ultrasound measures in the swallowing disorders diagnostic predictive model.

    Measured: Through study completion, an average of 2 years

Secondary outcomes (5)
  1. Accuracy and reliability of ultrasound measure of hyoid bone movement

    Hyoid bone displacement will be recorded during swallowing. The video clips will be recorded in an external hard drive and then analyzed. The resting position of the hyoid bone will be used as axis coordinate system. The distance between resting position and during swallowing highlights the hyoid bone displacement. The hyoid bone displacement in x (anterior displacement) and y (superior displacement) axis will be measured in centimeters.

    Measured: Through study completion, an average of 2 years

  2. Accuracy and reliability of ultrasound measure of the tongue kinetics

    M-mode will be used to measure the vertical movement of the tongue (distance, in centimeters). The ultrasound line represents the tongue surface. The signal amplitude allows the assessment of vertical distance between the ultrasound line in resting position and during the swallowing.

    The time between the start of the movement and the back to the resting position will be assessed.

    Measured: Through study completion, an average of 2 years

  3. Accuracy and reliability of ultrasound measure of the digastric muscles

    Linear transducer will be used to obtain a coronal plane of suprahyoid muscles: anterior belly of digastrics muscle. The muscles activity during swallowing will be recorded. The frames will be frozed allowing the measure of the muscle thickness and Cross Sectional Area (CSA) of anterior belly of digastrics muscle. Thickness will be measured with calipers. To CSA quantification, a region of interest will be delimitated using free mode calipers. The CSA image will be used to quantity the echogenecity (grey level) with Image J software.

    Measured: Through study completion, an average of 2 years

  4. Accuracy and reliability of ultrasound assessment of the geniohyoid muscle

    Two different methods will be used: M-mode and B-mode. M-mode will be used to quantify the geniohyoid thickness at resting position and during swallowing. The ultrasound line represents geniohyoid muscle surface. The signal amplitude allows the assessment of muscle thickness.

    With B-mode method, the geniohyoid muscle thickness at resting position and during swallowing will be measured. The thickness will be measured in centimeters.

    Measured: Through study completion, an average of 2 years

  5. Inter and intra-operator reliability assessment of the swallowing ultrasound assessment

    Two operators will repeat the previous described outcomes measurement three times.

    The second ultrasound operator will perform all sonographic measurements following the first operator. Both ultrasound operators will be blinded from the patient's information. The second ultrasound operators will be blinded from the first ultrasound examination.

    Measured: Through tweenty first inclusion completion, an average of 15 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2021
  2. Study start5 Mar 2021
  3. Primary completion4 Apr 2023
  4. Study completion4 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
Prospective interventional study including consecutive patients
Masking
None (open label)
Enrolment
124 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04800783
Sponsor's protocol ID
2020-A02942-37
Acronym
DARC-VADOC
Status last verified
Mar 2023
First submitted
2 Mar 2021
Last updated
11 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IPD data that underlie results in a publication will be uploaded in a repository platform.

Questions about this trial

What is this clinical trial studying?

A study testing Swallowing ultrasound in people with Deglutition Disorders, run by Hopital Forcilles at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Swallowing ultrasound predictive model development (time frame: Through study completion, an average of 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2023; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in